🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
End-stage liver disease due to hepatitis C virus (HCV) is the most common i...
Status
Unknown
Location
123, Ta Pei Road, Niao Sung Hsiang
Start Date
2014-01
Trial ID
NCT02160080
Treatments Being Tested
Analysis of HCV-specific T cell responses in patients treated with boceprev...
Status
Completed
Location
Unit of Infectious Diseases and Hepatology
Start Date
2012-04
Trial ID
NCT01403181
Treatments Being Tested
Hepatitis C virus (HCV) infection is a leading cause of death and illness i...
Status
Completed
Location
Alabama CRS
Start Date
2012-04
Trial ID
NCT01482767
Treatments Being Tested
The purpose of the study is to look at whether taking a new medication for ...
Status
Completed
Location
St Stephen's AIDS Trust
Start Date
2012-08
Trial ID
NCT01663922
Treatments Being Tested
The purpose of this study is to evaluate the impact of a physician directed...
Status
Completed
Location
California Liver Institute
Start Date
2011-12
Trial ID
NCT01405027
Treatments Being Tested
The hypothesis was to check whether baseline anti-E1E2 antibodies were corr...
Status
Completed
Location
Hôpital de la Croix Rousse
Start Date
2014-06
Trial ID
NCT02877199
Treatments Being Tested
Evaluation of efficacy of triple therapy with pegylated interferon, ribavir...
Status
Completed
Location
Haut-Lévêque Hospital
Start Date
2012-01-06
Trial ID
NCT01463956
Treatments Being Tested
This prospective, national, multicenter, non-interventional study examined ...
Status
Terminated
Location
Multiple Locations
Start Date
2014-05
Trial ID
NCT02118597
Treatments Being Tested
This study will assess the efficacy of boceprevir (BOC) in combination with...
Status
Completed
Location
Multiple Locations
Start Date
2011-10-21
Trial ID
NCT01390844
1. A maximally tolerated dose of ribavirin can be defined in each patient w...
Status
Unknown
Location
Liver Institute of Virginia
Start Date
2013-01
Trial ID
NCT01731301
Treatments Being Tested